pharma
Danger of Sanofi’s dengue vaccine confirmed in new study
June 14, 2018Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical
A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …
FDA knocks back Mylan’s Advair generic for second time
June 14, 2018Sales and Marketing Advair, FDA, GSK, Mylan, pharma
The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …
UK immigration rules to be waived to bring in more doctors
June 14, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The NHS’ recruitment crisis has been on-going for a number of years, with an ageing population and a higher workload …
Report highlights that half of women in science face harassment
June 14, 2018Medical Communications biotech, drugs, pharma, pharmaceutical
Arriving at a particularly low point for the reputation of the biotech, after STAT revealed that a party at BIO …
UK demand for mental health apps soars 566% since 2014
June 13, 2018Medical Communications, Research and Development UK, apps, mental health, pharma
A new report from communications and research agencies GK Strategy and onefourzero has revealed the massive extent to which consumer …
Vaccination rates in parts of US fall to dangerous levels
June 13, 2018Research and Development anti-vax, biotech, drugs, pharma, pharmaceutical, vaccination
The anti-vaxxer movement is the scourge of meticulously researched science and yet, in certain states in the US, it seems …
Celgene showcases strong Otezla data in psoriatic arthritis
June 13, 2018Research and Development Celgene, EULAR, otezla, pharma
Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …
J&J continues to shed assets, with $2.1bn diabetes unit sale
June 13, 2018Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …
Investors stump up cash for anti-ageing start-up
June 12, 2018Research and Development, Sales and Marketing Juvenescence, biotech, drugs, pharma, pharmaceutical
Defeating the ageing process is a pie-in-the-sky idea that has resulted, so far, in a rich vein of parody rather …
Brexit negotiations: Is the public’s health a priority?
June 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical
The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …
Research casts doubts over CRISPR safety
June 12, 2018Manufacturing and Production, Research and Development biotech, crispr, drugs, pharma, pharmaceutical
Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR …
Vical terminates genital herpes vaccine after trial failure
June 12, 2018Manufacturing and Production, Research and Development Vaccine, Vical, herpes, pharma
San Diego-based biopharma firm Vical has announced the disappointing, if unsurprising, news that it has taken the decision to terminate …
Allergan’s atogepant fulfils primary endpoint in episodic migraine
June 12, 2018Manufacturing and Production, Research and Development Allergan, atogepant, migraine, pharma
Allergan has made ground in its quest to become “the headache company” with the release of new Phase 2b/3 data …
Another failure in Alzheimer’s creates bleak outlook for treatment
June 12, 2018Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical
Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …
Alexion goes back to roots with Complement deal
June 11, 2018Manufacturing and Production, Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris
Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
